REinCARNATe™

A next-generation in vivo CAR T programming system. Lipid-nanoparticle or non-lipid carriers ferry optimized mRNA constructs that, upon administration, awaken circulating T cells with a bespoke chimeric antigen receptor—targeting tumor cells, pathogens, or autoimmune triggers without genomic integration or long-term modification.

Key features:

• Transient, non-integrating mRNA expression for enhanced safety

• Rapid on-demand manufacturing for emergent targets

• Scalability and stability designed for global distribution